Variant report
Variant | nsv438019 |
---|---|
Chromosome Location | chr8:4052459-4053079 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2552111 | chr8:4052459-4052460 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs564687217 | chr8:4052461-4052462 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73658469 | chr8:4052470-4052471 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs147022971 | chr8:4052476-4052477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568648025 | chr8:4052486-4052487 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs80349538 | chr8:4052497-4052498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs147550700 | chr8:4052534-4052535 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539559994 | chr8:4052536-4052537 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76865316 | chr8:4052553-4052554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2656298 | chr8:4052555-4052556 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs537642533 | chr8:4052587-4052588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556462300 | chr8:4052589-4052590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs71511195 | chr8:4052591-4052592 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2656299 | chr8:4052593-4052594 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182493771 | chr8:4052596-4052597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572038999 | chr8:4052601-4052602 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545956694 | chr8:4052606-4052607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs889991 | chr8:4052615-4052616 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531970617 | chr8:4052616-4052617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs185683277 | chr8:4052620-4052621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73658470 | chr8:4052630-4052631 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs190934189 | chr8:4052639-4052640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547651233 | chr8:4052671-4052672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565770467 | chr8:4052699-4052700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566106208 | chr8:4052703-4052704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182779009 | chr8:4052715-4052716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540338576 | chr8:4052719-4052720 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs114106727 | chr8:4052742-4052743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553540997 | chr8:4052743-4052744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs188894445 | chr8:4052747-4052748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114921546 | chr8:4052750-4052751 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs117266811 | chr8:4052782-4052783 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373733824 | chr8:4052783-4052784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs367564997 | chr8:4052813-4052814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542684095 | chr8:4052814-4052815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554095070 | chr8:4052817-4052818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs374534591 | chr8:4052823-4052824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148563752 | chr8:4052824-4052825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs377441420 | chr8:4052826-4052827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs193228517 | chr8:4052829-4052830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs372232076 | chr8:4052838-4052839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143059667 | chr8:4052843-4052844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375210650 | chr8:4052844-4052845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs115919268 | chr8:4052851-4052852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543474242 | chr8:4052856-4052857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562159147 | chr8:4052858-4052859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs889992 | chr8:4052860-4052861 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs183516605 | chr8:4052871-4052872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs889993 | chr8:4052872-4052873 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs536367801 | chr8:4052874-4052875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164920 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Prostate cancer | 17217626 | CNVD |
Developmental delay | 19128483 | CNVD |
Neuroticism | 17667963 | CNVD |
Leukoplakia | 24403051 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 22014273 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cancer | 20164919 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Schizophrenia | 21346763 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:4049800-4054000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr8:4050600-4053800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr8:4051000-4052800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr8:4051400-4053200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |